MannKind Corp (MNKD)
4.64
+0.02
(+0.43%)
USD |
NASDAQ |
Mar 19, 09:52
MannKind Cash from Operations (TTM): 34.09M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 34.09M |
September 30, 2023 | 10.04M |
June 30, 2023 | -26.70M |
March 31, 2023 | -61.28M |
December 31, 2022 | -80.68M |
September 30, 2022 | -90.65M |
June 30, 2022 | -77.76M |
March 31, 2022 | -67.23M |
December 31, 2021 | -61.71M |
September 30, 2021 | -49.13M |
June 30, 2021 | -47.40M |
March 31, 2021 | -29.64M |
December 31, 2020 | -28.13M |
September 30, 2020 | -33.47M |
June 30, 2020 | -72.06M |
March 31, 2020 | -88.10M |
December 31, 2019 | -88.48M |
September 30, 2019 | -58.39M |
June 30, 2019 | -20.26M |
March 31, 2019 | -27.68M |
December 31, 2018 | -37.73M |
September 30, 2018 | -92.70M |
June 30, 2018 | -102.05M |
March 31, 2018 | -94.94M |
December 31, 2017 | -64.78M |
Date | Value |
---|---|
September 30, 2017 | -47.55M |
June 30, 2017 | -47.35M |
March 31, 2017 | -38.82M |
December 31, 2016 | -78.09M |
September 30, 2016 | -87.89M |
June 30, 2016 | -84.71M |
March 31, 2016 | -91.01M |
December 31, 2015 | -57.23M |
September 30, 2015 | -70.42M |
June 30, 2015 | 49.70M |
March 31, 2015 | 44.10M |
December 31, 2014 | 4.086M |
September 30, 2014 | 5.779M |
June 30, 2014 | -127.37M |
March 31, 2014 | -133.70M |
December 31, 2013 | -128.73M |
September 30, 2013 | -122.78M |
June 30, 2013 | -124.13M |
March 31, 2013 | -119.40M |
December 31, 2012 | -119.86M |
September 30, 2012 | -112.12M |
June 30, 2012 | -113.89M |
March 31, 2012 | -125.62M |
December 31, 2011 | -123.84M |
September 30, 2011 | -142.45M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-90.65M
Minimum
Sep 2022
34.09M
Maximum
Dec 2023
-48.23M
Average
-53.76M
Median
Cash from Operations (TTM) Benchmarks
United Therapeutics Corp | 978.00M |
Corcept Therapeutics Inc | 127.04M |
Cassava Sciences Inc | -82.02M |
Amphastar Pharmaceuticals Inc | 183.50M |
Cogent Biosciences Inc | -153.62M |